Currently, the “color coding” project includes 100% of Cristália’s portfolio of injectable products targeting to enable an easier identification of the drug to be administered, therefore contributing to less administration errors
As most drug manufacturers do not manufacture products using packages that meet market’s needs, hospital pharmacies had to develop a true industrial production process.
Most drugs that reach to medical facilities cannot be distributed and administered in a safe manner. This happens because about 70% of everything produced by pharmaceutical industry are reserved to retail market, and are not addressed to hospital settings.
Such reality led Cristália to invest on innovation in the primary packages of its products addressed to hospitals, thereby implementing the following additional innovations in its packages:
The Brazilian regulatory authority (ANVISA) recommended some actions, including Resolution RDC 71, addressing the implementation of color-coded tags according to the therapeutic class to which a product belongs. While this approach is interesting and feasible, this is not a mandatory procedure. In spite of that, Cristália has decided to implement the recommendation, and, once again, had a breakthrough!
Today, “color coding” project includes 100% of Cristália’s portfolio of injectable products targeting an easier identification of the drug to be administered, therefore contributing to less administration errors.